MFIC Stock Analysis: MidCap Financial Investment | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 710m USD | 12M Return: -17.7% | US03761U5020 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.07M
EPS Trend: -91.0%
Qual. Beats: 3
Rev. Trend: 63.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
MidCap Financial Investment Corporation (MFIC) is a Business Development Company (BDC) and externally managed, closed-end investment company that specializes in providing debt and equity financing to private middle-market companies. The firm offers a broad range of financing solutions, including unitranche loans, first and second lien secured loans, senior secured and unsecured debt, mezzanine financing, and stretch senior loans, alongside equity investments such as preferred and common equity, warrants, and PIPE transactions. It also allocates capital to structured products like collateralized loan obligations (CLOs) and credit-linked notes (CLNs).
The companys investment focus spans a wide array of industries, including business services, healthcare and pharmaceuticals, energy, manufacturing, retail, aerospace and defense, telecommunications, financial services, consumer products, media, and transportation. As a BDC regulated under the Investment Company Act of 1940, MFIC is structured to provide capital to small and mid-sized private businesses that often lack access to traditional public financing channels, with a business model centered on generating income through interest payments and capital appreciation on its portfolio investments.
- SOFR rate cuts compress net interest spread and NII
- Middle market credit quality deterioration raises non-accrual risk
- Apollo sponsorship supports deal origination and capital deployment
| Net Income: -29.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 24.44 > 1.0 |
| NWC/Revenue: -23.25% < 20% (prev 37.77%; Δ -61.02% < -1%) |
| CFO/TA 0.19 > 3% & CFO 552.2m > Net Income -29.7m |
| Net Debt (1.70b) to EBITDA (93.9m): 18.06 < 3 |
| Current Ratio: 0.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (82.5m) vs 12m ago -11.88% < -2% |
| Gross Margin: 82.49% > 18% (prev 46.35%; Δ 36.14% > 0.5%) |
| Asset Turnover: 8.23% > 50% (prev 6.77%; Δ 1.45% > 0%) |
| Interest Coverage Ratio: 0.78 > 6 (EBIT TTM 93.9m / Interest Expense TTM 121.1m) |
| A: -0.02 (Total Current Assets 64.6m - Total Current Liabilities 125.0m) / Total Assets 2.86b |
| B: -0.50 (Retained Earnings -1.44b / Total Assets 2.86b) |
| C: 0.03 (EBIT TTM 93.9m / Avg Total Assets 3.16b) |
| D: 0.63 (Book Value of Equity 1.10b / Total Liabilities 1.76b) |
| Altman-Z'' = -0.93 = CCC |
As of October 07, 2026, the stock is trading at USD 8.50 with a total of 785,985 shares traded. Over the past week, the price has changed by -4.06%, over one month by -8.06%, over three months by -11.96% and over the past year by -17.65%.
Current recommended Stop Loss: 8.20 (which is 3.5% or 1.6 ATR below the current price).
MidCap Financial Investment has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold MFIC.
- StrongBuy: 2
- Buy: 1
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 10.4 | 22.5% |
P/E Forward = 7.2046
P/S = 2.3591
P/B = 0.6653
P/EG = 3.1217
Revenue TTM = 260.0m USD
EBIT TTM = 93.9m USD
EBITDA TTM = 93.9m USD
Long Term Debt = 1.61b USD (estimated: total debt 1.74b - short term 125.0m)
Short Term Debt = 125.0m USD (from shortTermDebt, last quarter)
Debt = 1.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.70b USD (calculated: Debt 1.74b - CCE 43.3m)
Enterprise Value = 2.41b USD (710.1m + Debt 1.74b - CCE 43.3m)
Interest Coverage Ratio = 0.78 (Ebit TTM 93.9m / Interest Expense TTM 121.1m)
EV/FCF = 4.36x (Enterprise Value 2.41b / FCF TTM 552.2m)
FCF Yield = 22.95% (FCF TTM 552.2m / Enterprise Value 2.41b)
FCF Margin = 212.4% (FCF TTM 552.2m / Revenue TTM 260.0m)
Net Margin = -11.40% (Net Income TTM -29.7m / Revenue TTM 260.0m)
Gross Margin = 82.49% ((Revenue TTM 260.0m - Cost of Revenue TTM 45.5m) / Revenue TTM)
Gross Margin QoQ = 90.80% (prev 88.92%)
Tobins Q-Ratio = 0.84 (Enterprise Value 2.41b / Total Assets 2.86b)
Interest Expense / Debt = 6.96% (Interest Expense 121.1m / Debt 1.74b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 74.2m (EBIT 93.9m * (1 - 21.00%))
Current Ratio = 0.52 (Total Current Assets 64.6m / Total Current Liabilities 125.0m)
Debt / Equity = 1.58 (Debt 1.74b / totalStockholderEquity, last quarter 1.10b)
Debt / EBITDA = 18.06 (Net Debt 1.70b / EBITDA 93.9m)
Debt / FCF = 3.07 (Net Debt 1.70b / FCF TTM 552.2m)
Total Stockholder Equity = 1.24b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.94% (Net Income -29.7m / Total Assets 2.86b)
RoE = -2.39% (Net Income TTM -29.7m / Total Stockholder Equity 1.24b)
RoCE = 3.29% (EBIT 93.9m / Capital Employed (Equity 1.24b + L.T.Debt 1.61b))
RoIC = 2.61% (NOPAT 74.2m / Invested Capital 2.85b)
WACC = 6.17% (E(710.1m)/V(2.45b) * Re(7.81%) + D(1.74b)/V(2.45b) * Rd(6.96%) * (1-Tc(0.21)))
Discount Rate = 7.81% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 70.72 | Cagr: 11.01%
[DCF] Terminal Value 75.44% ; FCFF base≈552.2m ; Y1≈554.5m ; Y5≈587.3m
[DCF] Fair Price = 90.31 (EV 9.14b - Net Debt 1.70b = Equity 7.44b / Shares 82.4m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: -90.95 | EPS CAGR: -6.44% | SUE: 2.93 | # QB: 3
Revenue Correlation: 63.45 | Revenue CAGR: 2.52% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.36 | Chg30d=+8.90% | Revisions=+67% | Analysts=8
EPS current Year (2026-12-31): EPS=1.49 | Chg30d=+7.13% | Revisions=+73% | GrowthEPS=-1.7% | GrowthRev=-16.8%
EPS next Year (2027-12-31): EPS=1.25 | Chg30d=+1.00% | Revisions=-18% | GrowthEPS=-16.5% | GrowthRev=-10.8%
[Analyst] Revisions Ratio: +48% (up=17, down=5)